The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Shallcross Steven A since 2006.
This trader's CIK number is 1263501.
At the time of last reporting, Shallcross Steven A was the CEO and CFO of Theriva Biologics, Inc.. (stock ticker symbol TOVX).
Also see all insider trading activities at Theriva Biologics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | TOVX | 240,000 | $159,984 | 0 | $0 | 0 | $0 |
| 2021 | TOVX | 50,000 | $24,600 | 0 | $0 | 0 | $0 |
| 2019 | TOVX | 50,000 | $20,800 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | VNDA | 0 | $0 | 33,000 | $621,168 | 33,000 | $53,070 |
| 2006 | VNDA | 0 | $0 | 10,000 | $264,500 | 10,000 | $8,300 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | CMXI | 79,500 | $30,730 | 0 | $0 | 0 | $0 |
1. Theriva Biologics, Inc. (TOVX)
2. Vanda Pharmaceuticals Inc. (VNDA)
3. Nuo Therapeutics, Inc. (CMXI)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-07 | TOVX | Buy | 14,000 | .69 | 9,702 |
| 2023-06-06 | TOVX | Buy | 26,000 | .63 | 16,458 |
| 2023-02-10 | TOVX | Buy | 25,000 | 1.04 | 26,074 |
| 2023-02-02 | TOVX | Buy | 25,000 | .94 | 23,525 |
| 2023-01-25 | TOVX | Buy | 25,000 | .87 | 21,825 |
| 2023-01-20 | TOVX | Buy | 25,000 | .75 | 18,700 |
| 2022-12-29 | TOVX | Buy | 100,000 | .44 | 43,700 |
| 2021-05-10 | SYN | Buy | 50,000 | .49 | 24,600 |
| 2019-08-23 | SYN | Buy | 50,000 | .42 | 20,800 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-11-28 | VNDA | Option Ex | 3,300 | 2.78 | 9,174 |
| 2007-11-28 | VNDA | Sale | 3,300 | 9.00 | 29,700 |
| 2007-10-16 | VNDA | Option Ex | 3,300 | 2.78 | 9,174 |
| 2007-10-16 | VNDA | Sale | 3,300 | 17.93 | 59,169 |
| 2007-09-18 | VNDA | Option Ex | 3,300 | 2.78 | 9,174 |
| 2007-09-18 | VNDA | Sale | 3,300 | 14.81 | 48,873 |
| 2007-08-21 | VNDA | Option Ex | 3,300 | 2.78 | 9,174 |
| 2007-08-21 | VNDA | Sale | 3,300 | 15.21 | 50,193 |
| 2007-07-17 | VNDA | Sale | 3,300 | 20.63 | 68,079 |
| 2007-07-17 | VNDA | Option Ex | 3,300 | .83 | 2,729 |
| 2007-06-19 | VNDA | Sale | 3,300 | 21.19 | 69,927 |
| 2007-06-19 | VNDA | Option Ex | 3,300 | .83 | 2,729 |
| 2007-05-15 | VNDA | Option Ex | 3,300 | .83 | 2,729 |
| 2007-05-15 | VNDA | Sale | 3,300 | 19.39 | 63,987 |
| 2007-04-17 | VNDA | Sale | 3,300 | 21.58 | 71,214 |
| 2007-04-17 | VNDA | Option Ex | 3,300 | .83 | 2,729 |
| 2007-03-20 | VNDA | Option Ex | 3,300 | .83 | 2,729 |
| 2007-03-20 | VNDA | Sale | 3,300 | 23.08 | 76,164 |
| 2007-01-16 | VNDA | Option Ex | 3,300 | .83 | 2,729 |
| 2007-01-16 | VNDA | Sale | 3,200 | 25.41 | 81,302 |
| 2007-11-16 | VNDA | Sale | 100 | 25.60 | 2,560 |
| 2006-12-11 | VNDA | Option Ex | 10,000 | .83 | 8,300 |
| 2006-12-11 | VNDA | Sale | 10,000 | 26.45 | 264,500 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-08-26 | CMXI | Buy | 27,500 | .38 | 10,450 |
| 2014-08-20 | CMXI | Buy | 52,000 | .39 | 20,280 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shallcross Steven A (CEO and CFO of Theriva Biologics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.